Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
149.56
+0.44 (+0.30%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Warning! These 3 Blue-Chip Stocks Will Have You Seeing Red
Today 16:30 EDT
These stocks are underwater right now and likely to remain so as the companies behind them manage serious problems.
Via
InvestorPlace
No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
Today 9:20 EDT
The company is establishing its line-up of drugs behind bread-and-butter med Ingrezza.
Via
Investor's Business Daily
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
April 22, 2024
From
Johnson & Johnson
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
April 22, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Unpacking the Latest Options Trading Trends in Johnson & Johnson
April 18, 2024
Via
Benzinga
3 Dividend Stocks to Buy Now for Lifelong Income
April 22, 2024
Here are three dividend stocks to buy now offering stability, growth, and lifelong income in the pharmaceutical and tobacco industries.
Via
InvestorPlace
5 Crash-Proof Stocks to Buy Immediately
April 22, 2024
We may not be headed to a full-blown crisis, but savvy investors should protect their portfolios now with these crash-proof stocks.
Via
InvestorPlace
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
April 22, 2024
These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more.
Via
InvestorPlace
MarketBeat Week in Review – 4/15 - 4/19
April 20, 2024
The markets continued to move lower ahead of a big earnings week as analysts adjust valuations on the outlook for interest rates and geopolitical concerns
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Investing for the Long-Term: 3 Stocks With Proven Track Records
April 20, 2024
As uncertainty in the global economy and geopolitical climate abounds, investors should focus on stocks with proven track records.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
April 19, 2024
Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.
Via
InvestorPlace
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
April 19, 2024
The Nasdaq and S&P 500 tumbled below their 50-day lines.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
April 19, 2024
Discover the impact of Brexit on UK drug shortages. Insights from a recent Nuffield Trust study reveal a doubling in shortages since 2020. Learn about challenges in medicine supplies, regulatory...
Via
Benzinga
Topics
Brexit
Exposures
Brexit
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert
April 19, 2024
WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detected in Benylin syrup prompt recalls across Africa. Investigation is underway.
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
April 19, 2024
Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel
Via
Benzinga
Exposures
Product Safety
Top Stock Reports For Nvidia, Alphabet And Johnson & Johnson
April 18, 2024
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson & Johnson (JNJ).
Via
Talk Markets
Recession-Proof Riches: 3 Stocks That Thrive in Any Economy
April 18, 2024
Discover recession-proof stocks that thrive amid economic uncertainty, offering stability and consistent growth.
Via
InvestorPlace
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
April 18, 2024
Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.
Via
InvestorPlace
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
April 17, 2024
Johnson & Johnson reports first-quarter earnings, with adjusted EPS up 12.4% and sales up 2.3%. Analysts optimistic about stock's future, highlighting potential growth from new drug approvals. JNJ aims...
Via
Benzinga
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
April 17, 2024
Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday.
Via
Benzinga
Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough
April 17, 2024
Although monetary policy seemed to be moving in a dovish direction, a pivot may warrant a look at stocks for Fed hikes.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Put $10,000 in These 3 Dividend Stocks by 2025
April 17, 2024
In market uncertainty, dividend stocks come to the rescue. Rebalance your portfolio with these three dividend stocks and enjoy steady income.
Via
InvestorPlace
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
April 17, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
April 17, 2024
Johnson & Johnson's Q1 2024 earnings offer a mixed picture of resilience amidst economic headwinds and provide insight into the broader medtech sector's health.
Via
MarketBeat
Topics
Economy
Exposures
COVID-19
Supply Chain
Why Johnson & Johnson Stock Got Tossed by the Market Today
April 16, 2024
A mixed quarter and narrowed guidance didn't really please investors.
Via
The Motley Fool
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
April 16, 2024
JNJ earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
April 16, 2024
Investors remain on edge as geopolitics continue to shape market trends, with Israel mulling a response to Iran while the U.S. and key allies explore further sanctions against Tehran.
Via
Benzinga
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
April 16, 2024
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost...
Via
Benzinga
JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024
April 16, 2024
JNJ stock results show that Johnson & Johnson beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.